Found 7 matching trials
Nivolumab Combined With Anlotinib as Re-challenge Treatment in Advanced NSCLC
PHASE1This is a phase Ib/IIa, open-label, single center study, aiming to investig...
Location
Shanghai Chest hospital
Anlotinib Combined With Nivolumab for Non-Small Cell Lung Cancer
PHASE2This study evaluates the safety and efficacy of anlotinib in combination wi...
Location
Multiple Locations
Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors
PHASE1This study evaluates the safety and efficacy of AL3818 (anlotinib) hydrochl...
Status
Active Not Recruiting
Location
Sarcoma Oncology Research Center
TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Advanced HCC
N/AThe purpose of this study is to evaluate the safety and efficacy of transar...
Response to Neoadjuvant Treatment in Locally Advanced Thyroid Cancer
N/AThis multicenter observational study aims to evaluate the safety and effica...
Location
Fujian Medical University Union Hospital
Efficacy and Safety of Anlotinib Hydrochloride Combined With Nivolumab in the Treatment of Gastric and Esophageal Cancer
PHASE2Patients with unresectable or metastatic gastric or esophageal cancer, with...
Location
Multiple Locations
TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Intermediate HCC
N/AThe purpose of this study is to evaluate the safety and efficacy of transar...